Rapport Therapeutics, Inc. RAPP
NASDAQ · United States · Health Technology
$32.68-0.15 (-0.46%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -1.19 | -0.96 | -23.6% | $0 | — | +9.8%$42.20→$46.35 |
| Q1 2026 | 2026-05-07 | -0.42 | -0.56 | +25.0% | — | — | +2.6%$37.06→$38.04 |
| Q4 2025 | 2026-03-10 | -0.72 | -0.67 | -7.5% | — | — | 0.0%$30.54→$30.54 |
| Q3 2025 | 2025-11-06 | -0.71 | -0.77 | +7.8% | — | — | -1.9%$26.17→$25.66 |
| Q4 2024 | 2025-03-11 | -0.57 | -0.70 | +18.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.